Skip to content

Opening book details…

About this Medicine article

469P Efficacy and safety of anlotinib combined with CAPEOX in first-line treatment of patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer - A single-arm, multi-center, phase II study (ALTER-C-002 trial) by Ding, K.; Liu, Y.; Chen, J.; Ying, J.; Xu, Q.; Xu, D.; Sun, L.; Yuan, Y. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ding, K.; Liu, Y.; Chen, J.; Ying, J.; Xu, Q.; Xu, D.; Sun, L.; Yuan, Y.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2020
Field
Medicine (Health Sciences)

More by Ding, K.; Liu, Y.; Chen, J.; Ying, J.; Xu, Q.; Xu, D.; Sun, L.; Yuan, Y.

Browse all works by Ding, K.; Liu, Y.; Chen, J.; Ying, J.; Xu, Q.; Xu, D.; Sun, L.; Yuan, Y.